Evidence map›Paper›PMID 42871301›Full record

ArticleAME case reports2026

Late-onset ankylosing spondylitis presenting with severe flank and abdominal-to-back pain in a 64-year-old man: a case report.

Naoki Kondo

Abstract readCase Reports
In one paragraph

Article in AME case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Naoki KondoDivision of Orthopedic Surgery, Department of Regenerative and Transplant Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.ORCID https://orcid.org/0000-0002-8985-3055

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine and sacroiliac joints and is typically diagnosed in younger adults. However, AS may be overlooked in older patients when symptoms are atypically localized, such as flank or abdominal-to-back pain, rather than classic inflammatory low back pain. Case Description: We report the case of a 64-year-old man who presented with persistent left-sided abdominal-to-back pain accompanied by markedly elevated inflammatory markers. Initial evaluation focused on abdominal, urinary, infectious, malignant, and degenerative spinal disorders. However, imaging revealed bilateral grade 3 sacroiliitis according to the modified New York criteria, marked narrowing and partial anterior fusion of both sacroiliac joints on pelvic computed tomography (CT), and lumbar vertebral corner ossification. Human leukocyte antigen (HLA)-B27 was negative. Based on the overall clinical and radiographic findings, late-onset AS was diagnosed. After diagnosis, adalimumab (ADA) was initiated and rapidly improved disease activity. Because its efficacy later waned, treatment was switched to infliximab (IFX), which restored disease control. Although disease activity worsened after switching to an IFX biosimilar, reintroduction of originator IFX restored clinical remission, which was maintained for 2.5 years without serious adverse events. Conclusions: This case highlights that late-onset AS may present with atypical flank and abdominal-to-back pain rather than classic inflammatory low back pain. In older patients with unexplained persistent flank or abdominal-to-back pain and markedly elevated inflammatory markers, AS should be considered in the differential diagnosis after excluding abdominal, urinary, infectious, malignant, and degenerative spinal disorders. Careful differentiation from diffuse idiopathic skeletal hyperostosis (DISH) is particularly important when extensive spinal ossification is present.

Indexed as

Ankylosing spondylitis (AS)case reportdiagnosisefficacytumor necrosis factor inhibitors (TNF inhibitors)

Identifiers

PMID42871301
PMCPMC13659156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.